Your SlideShare is downloading. ×
24 bone pathology
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

24 bone pathology

256
views

Published on

Published in: Health & Medicine

1 Comment
0 Likes
Statistics
Notes
  • Focal osteoporotic marrow defect: khiếm khuyết tủy xương do loãng xương (theo sách BH miệng, ĐHYD TPHCM)
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

No Downloads
Views
Total Views
256
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
13
Comments
1
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. ! "# $ %"& () # $!"# $ # !" % # " # # "
  • 2. Kh i u Kích ho tT ox ng m i osteoclast !" H yx ng Kích ho t # $ osteoblast # %
  • 3. & !"# $ ! % & % ( !" )
  • 4. T n th ng x ng (Bone Lesions)• R i n di truy n (Hereditary Disorders)• R i n chuy n a (Metabolic Conditions)• T n th ng s i-x ng nh nh (Benign Fibro- Osseous Lesions)• Tân sinh (Neoplasms)• Ph i h p (Miscellaneous conditions)
  • 5. & ( ) * + - ,*+ % , ( -*# . $ !" / $ 0 " " 1( $ 2 *) 3 % , ! 4 , ( " *$ 5 !" - & 6 * "1 3 % 7& !" 8 " !7 & 8 : " & 9: ; !" !" < 3 . = , 0 6 5 5 6
  • 6. # ) . ) ! ( / 0 *+ 2 , 6 , >1 % 4 ! % 7 3 3 ? @@ 41 3 5- 1( ,* $A ,. 9:4 " ? 3B 4 7 & CD<*) 3 1 , & 0 " E 4 6A #F ; 5 ;*) 3 % , ! 4 3 1 % , -* G : " !" ; !" 3- 3% 2*? - % 741 3 & 0 - -* 2 3- 4 3 3% 2 ;:*? 5 6 . & 3 !" 4 !" !"
  • 7. 0 1 2 $ !"$ 2 6 , !" &" ! 2 !" !" &( " 6 & ! /!" 76 4 6 !" 4" ! 4 2 1 !" & % % !" 5* @H ; 5* B 5 " !" !" $ 3 @ H @!7* < , !" 0 !" 6 * I !" 4 7 !" 4 !"* J 2 5 E , K 3- !" 8 :* > $ !" L " > M N O L ! !P* >!" " 0 & 1 " !7 1 % 2Còn có m t b nh Paget v da u vú có liên quan n ung th vú. ây ch nói n b nh Paget x ng. B nh này c mô t l n utiên n m 1877 b i BS James Paget, v sau ông c phong t cSir James Paget.
  • 8. 0 1 ( , - $? 3$) & 3 , & E & Q#3* K 6 0 - ! 6 , ( 3 1 6 5 O R P > $4 M " >* S 3 2 & %* ? 5 6 3 ,. !" F 3 2
  • 9. 0 1 ( , - $ * " * $ !" ( !" T !" E 6 L % 1 % " 4 2 !" 4 5↑C1 !" U & B ( ? !" ↑ % % !" 56 7 81 5 B$ ? & C % . 6 ! E . & % 3 !" := % 3 !" % , B !" % 5 & 3 !" "
  • 10. 0 1
  • 11. 0 1
  • 12. 9 " 4 7 $ : : $ : : ;* $ 5 !" 3% !"* V L " !" 1 5 0 &* ; ; 5 U !7 H F#* > M H > $U & %!" H & * $ 5 !" !" M !" - 6!" !7* ) 3 % , !# 3*$ - 4 , 5 L 0 5 J" % 7*$ 5 !" 3 " 0 L & !" & 3 3% 2*? 5 6 . *< , 5. 5 !" & - *@ 0 5. W 5 !" % 2 1 W !" (
  • 13. 9 " 4 7 $* "* $ 5 !" 0 1 5 0 9F ; 34 0 3 31 "? 5 6 . F@ !" ( FX 3 % R % % !" , J 3 6 51 3 F@ 0 5. ( ? % 6 7 8* @ !"* $ 9N ;:* $ 3 !"* ) 3 2 X 3
  • 14. <4 4 7 $ : =* 89: %!" 5 # U !7 H ;* > M !& %!" 6 YU 56 - 6!" !7* $$ 3 Z $$ 1 3 3 . N$ 5 !" 3 .6 4 % 5 4 3 3 4 " & !" 4 @ % 5 " N$ .8 9: $$ 3 : " $$ 1 3 3 N) , % & 0 L 3
  • 15. <4 4 7 $
  • 16. <4 4 7 $$$ 1 1 5 0. N !" 3 % !" , F6 , W 5 6 3 2 ? - , 4 2 C4 Q4 "4 0 34 4 2 * ?!" , 3 . 2 ? [4 [ !" 8 ; 9F : U;: 2 U F : ] % 3 NI 0 %QF / , ^ 0 " , U , 1 * ?!" , ! , . 49 % _% 4 4 2 !" N ( % , % 3@=$ !" 4 3 3- > $ 4 N , " 0 1 % _% . N @ !" ( . 4 0 > M4 1 % , 6 0 &" !7 & 1 5 0 % 3
  • 17. 0 " ) $ $*M % 0 % , % 3@=$ !"* ) 3 L 6! % / O % PF 1* N9 5* $ % 5 , & ! 5 , (* 34 0 > M4 3 6 1*M , O ^ !" 3 %" PN 6 , " " !" ^& ^*K 0 & !" 5* 2 &Q%E4 L 0
  • 18. $# 3*$ - 4 0 5* 6 7 & ! ^ / 3*= 5 6Q 4 , ( 1E " O % P: ) >* $!" ! 1 5 0 @ ! K= & >S 1* < 3 " ! & 1 5 0 " & 1 % "* + 0 ! -6 7 8* $ 3 !" . 1 3 6 %!" 6!"* ? "6 5 , (4 0 5 %
  • 19. ? < $ 0 @ $) 0 ) 3 " 5 3*J F !"*`a 0 !"*$ !" " !" 4; ; F 5*> M 0 U& % 2*Y : ; "*) 3 % , ! U , 1 - !" -* ;: 1 ! 1 3 6#3* $ - % 7* 3 7 A B C " 2 A D 8 " E* 1 ( 0 5 -
  • 20. ? ?: ) >*) 1 & 46!" " 3 31 " T / !"*) 3 T ! &* W # % /*? 5 6 6 0 ! & 3 4 - & 1 / ,6 7 8* < 5 * $ 3 !"
  • 21. ? ) $ " ;F $ 0 F0> T % !" 1E !" 6 5 ! 6 0 46!" " 3 31 " /&" !" !*? !" UQ U 3*J . 1 5 0 % 3& !" ( 3- &"* 0 " !" U # ] ; 5* $$ " !" N A :U ; 5*) 3 ! 1 , & 0 " E 4 0 "& > M*) ! 0 " 4 U 6#3* 5 0 5 - 4 0 !" 6 L* 36 5 -
  • 22. ? ) $ " F0K / ,4 3% !" ! !O P* "> 1E !" 6 5 ! 6 0 4 - 3 31 " & 1 5 0[ !"? 1 3 6!" " , 3* ; %!" : " !" ( 1 " &"1 5 0 % 3 L $$ " F !"6 7 8*@ & 6 31 ^*$ N FY: : ;* $K 1 3 5 !"*$ 3 3 !" 4
  • 23. <4 "; G $F ? - %( 3!" ( !" " 3 " ! 5 1F 0 5 !" % 5 4 ! & 3F< 3 5 !" ! % %!" " &( & , 3 , !7 3 4 - > & 3 % - % K " b % K !" F 3 2 ? F K !" F 3 2 1 % K !" F 3 2 - K !" F 3 2 % 5 3 2 1 5 0# !" " !" c _ _% + 3 " M_ _ = % c
  • 24. = " ";& ) , &,) 3 % , ! 4 3" 3!" &$! " 1 3 5 !" 3 ! !*I , " J@C=? ( K= " !" .F< , !" < .1 % " , !" $ 3 !" " 4F@ 0 !" B . 3- 0 !" = L , ! < ? FC % . " 0 !" [ / ^ _ !7 [ , ( " , ! d_ . 1 3 _ K ,
  • 25. = " " 4$ * & ) ,* N ; 9: %!" " U !" Q !" 0*< 4 ) 7 $H E* I!" 5 6 %!" ; 5* > $ H MU > e !7* @ ! % 5 " 5 ;* $ 5 !" > $ !" 3- 6 !" 1 , N L - E &,
  • 26. = " " 4$#3* ( - 1E " J% * I!" & 0 1 3 % 7* B 0 & !" 6 L 4 5 6 , 3% 2* + - . 1 M?@? & " %* $ 5 !" > $ (
  • 27. = " " 3 7 1 & ) ,I * F 5 / ^ & % ,[ " 0 !" 6 L , !" L $ 5 !" N K , N , ( " 4 K ! 2 34 4 ,I J- 1 -5 3 K ,
  • 28. McCune-Albright syndrome
  • 29. = " "* "* ? 6 !" 5 % 3 0 3 31 " !" ( !"* !" !" O !7 P* >!" 5 !" / , !" ( !"* $ %!"6 7 8* = 6 5 %! $$ 1 3 % " ? "6 5 %!"* 9: F 9;: 1** ? cf@J ? g Ih >Ci $ h @
  • 30. Fibrous Dysplasia (FD)
  • 31. = " ; $ A $ ;( ) ,$ 5 !" " F !" !" L " !"*> % " & % 2*# .1 % U- U % 5 = " #;#* & $ ; ) !*< , &Q%E*G : ; % " !7*# FY ; ; 5*@ !" % ^ !" L "*B 0 > M*) 3 % , ! 4 , 1 >- !" ->-*$ 6 5. - L - &" " - " &*$ !" L " . 5 " &! - &! -
  • 32. = " ; $ A= " ; $ A 3 )*S %!" !"* @!74% 34 3 < 74 3 B* # F9; 5 ;*$ % 2 >-*=" . - - &" . & -*< , . & 0 -*$ 5 !" %!" . &! - &! -
  • 33. Periapical Cemental Dysplasia
  • 34. = " ; $ A= " #;#* 4 0 $ A !" 4 7*@ 0 5* > M. %!" Z * @!74% 34 3 < 74 3B* 1 " 0 !* `a & % 2 / % 2
  • 35. Florid Osseous Dysplasia
  • 36. = " ; $ A< 3 ,*# 6 0 ( & 5*? 3 " &" 1 !" & 3 2* ?I . !" " !" c _ _%*B / , . !" " !" 2 % 7% &" !" % 1 !" F 3 2 E ! & / &"7* M! . 1 6Q 1(* $ 3 !"*@ " ! N (1 3 3 L 5% 2F& 3
  • 37. 0 " ( - & $*$$ 3 ! ! &" 3 " 4 ! 1 !" 4 3 2 L*I , 5 " 46A #F ; 5 ;* @!7 H U M H> $ >*+ % 2 !"* $$ N1 3 3% , !* $$ " N 1 ! 0 1 3 6* O !" " !" 3P>-* 5 - % 7* $$ " . 2 !" & > M
  • 38. 0 " ( - & $
  • 39. 0 "< 3 ,* < 3 " &" 1 1 " 0 ! 6 ,I 0 %Q* U 3 !"
  • 40. 0 2 : ! !" !" !" E 0 !" 6 L & !" %!" J" " !" LI : ! J % , % 3@=$ !"* 0 j@ 0 " 6 %! % E 6( 7 5 % j !" !" G : %!" ; " !" " !" 4 7 Z> M j@ 5 (" jX " M % " 3 5 j$ 2 , ^ %I 0 %Q & 3 !"*I 5 #4 : @ 7 Q % ; 9; 6 %! % U ^ 6 % !
  • 41. 9 $ A $ $ H $ A "*$ 5 !" 3 3 3 2 * > M H> $ 4 ; G: % "& % 2* 9; Kk @ SXC@ : lm ?cfkK`D@* $% & !" %*I & 6 34 6 1 %* =! 0>-*) - " &" 0 3 & 6!" - " & 0 -I!" & 0 3 " " &" % 2< 3 ,*? 1 / 3 " &" 1 5 06 3I 0 %Q*B / , 5 !" & % 2
  • 42. @ $ ( $*$ 5 !" E % 3 !" !" ! %!"*c % !" .Y F % : : %*# F ; ; 5 31 ; 9 F 5 6 &" !"* > Me> $* =! 46 4 4Q & 7>-*I . - U&! - &! - U -* @ & 1 3 % 7U 3 3 4 ,3 ( L %" O % % % P* , 1 M?@? 6 !
  • 43. ( $*< 3 ,*= %! !" " E*I 3 4 3 & 1 " 3 7 6!" I 0 %Q & 3 !"* B Cn $ XCo$ ?Cp$ ca cCq@ $cCq@ X*I 3!* $K # F9; ; :U 2 54 7
  • 44. Osteosarcoma
  • 45. @ $ " ! $* F# "& : 6 0 5* $$ !" . @ " 5* $$ !" . !" % " ] ; 5 U% ( e Y 5* > $ H> M*) 1 3 6* ( - 1 3 % 7 &" & - 4 ( L %" O= % P*J / , . $ 0 6 . %!" & I 0 %Q .* B Cn $ XCo$ ?Cp$ ca cCq@ $cCq@ @JCr $sq ICtX X*B / , ^ % , 6 5* 2*$A , 9. :
  • 46. 0 ! A $*K ! !" !" L*< K) $ 2 2 7 E*? % 54 , 7 %* 0 @ !" " 5*H;: 2 !" " M* K= 6 .1 ! 6 4 4Q* 1 1 3 % , !*B , 1 & !" 1 3 5% 2* +Q%E. % 2 54 2 6 % 54 2 %*$ - 1 3 6 0 , L 2F* 3 / Q - %* $ 3 !" U 0 @ 2
  • 47. * @ 5* ? % 3 , 4 2 5 & !" !"* I 4& !" 1 3 5% 2
  • 48. 8.16.2005 9.9.2005
  • 49. 10.07.2005
  • 50. & ! !"* I 6 0 %Q 6 0 %Q 0 6 3&" * $ 5 !" !" & L H 0* $ 0 ! 1 3 %Q& L
  • 51. u* M 6 0 %Q ! N I < N !" 6 L = % * + 4 0 ,4 5* K 7 !"* ? " G % ,; 6!" 1 3 % 3$J
  • 52. v % & % @6 " !" 4 5 4 46 % 2 & 3$ 5 !" !" % 0 5% 2@ ! 7 5 ! 0 !" % 2@ 0 %!" " ! !" ! 7 6!"$A , ! ! ( ! % 74 ! 1 ; 6!" :
  • 53. $ " 6 0 %Q&" 3 ( , ! !" (& / !) 6 0 %Q 5 !" 6 01 &" 1 I 0 %Q , " %! 54 3 !4 ^ & 6 31 ^ !"? , ! 6 , % 3 & &" 3 %!" 3
  • 54. 6 5 0 ". ) % 2 , 5 , %!" 1 6 0 %Q&" 4 5% 2 0 %!" 1 ^ 6 0 6 0 %Q @6 7 L 6 4 0 3 ^ 1 , 5 - ! ^ 4 3 3 E & 1 =
  • 55. LMN9 ?:9L O <(N I(FP.<QR #QO?: * IFS$ @ 3% ^ N $ 0 2 v HC% H% N $ 5 N I!" w N K ! N $ " 6 0 %Q N K 0 B$ 5N / , N $ " B N @ 5% 2 N k r 1 N B / , & - N I 0 %Q %? % N B / , !" N %Q$ 5F / N N I 0 !" 46!" N I 6!" 33 N @ , %!" N , & , 6 1 N += % 2 , 1 N C
  • 56. * 1 $ , !< ) -0 ) ) ) T ! - ( - +E JFrom Jules: Of note, in this Table it is reported that there were 13 cases (87%) for patients withosteoporosis and taking alendronate and 1 (7%) taking risendronate; is this because risendronateis less potent; perhaps, but maybe its safer.
  • 57. !" ()" &# * + , (" - # .
  • 58. Dr. Mark Bernstein, Univ. of Louisville
  • 59. Dr. Michael Rohrer, OMFP, UMNSOD
  • 60. !" + 34" &#5 "6 78 # 9 # 86# # " :" -; "4<=" -> % & ::?2)!" . $# # /0 2( 10

×